US equities
|
TSLA
$395.18
▲+6.17%
MU
$907.15
▲+3.37%
SPCX
$148.68
▲+0.81%
NVDA
$215.77
▲+2.28%
META
$642.16
▼-0.07%
AAPL
$343.41
▼-1.24%
SNDK
$1,263.48
▲+2.06%
INTC
$91.28
▲+4.97%
TSLA
$395.18
▲+6.17%
MU
$907.15
▲+3.37%
SPCX
$148.68
▲+0.81%
NVDA
$215.77
▲+2.28%
META
$642.16
▼-0.07%
AAPL
$343.41
▼-1.24%
SNDK
$1,263.48
▲+2.06%
INTC
$91.28
▲+4.97%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Hartaj Singh
Recent news which mentions Hartaj Singh
Moderna Analyst Projects Transformation Into 'Five-Product Commercial Company' By 2026
January 02, 2024
Tickers
MRNA
Tags
Price Target
Market News
Upgrades
From
Benzinga
Pittsburgh-based biotech company on a growth path
September 21, 2021
Tickers
INNO
Tags
Dietrich Stephan
Hartaj Singh
Sandra Rojas/Caro
From
Business Journals
If Moderna Is 'Executing Superbly' On Its COVID-19 Vaccine Portfolio, Why Is This Analyst Downgrading The Stock?
August 06, 2021
Tickers
MRNA
Tags
Health Care
Downgrades
Earnings
From
Benzinga